News
The approval of Moderna's Spikevax for kids at higher risk of contracting the disease continues the company's regulatory ...
Shares of Moderna (NASDAQ:MRNA) have been long forgotten about since its demand for COVID shots fell off a cliff more than ...
The label for Moderna's RSV vaccine mResvia has been expanded to include adults aged 18 and over in the US, but will that lead to an uptick in sales?
Moderna has secured FDA approval for its RSV vaccine, setting up a three-way market battle with GSK and Pfizer.
Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...
Arboviruses are spreading beyond tropical and subtropical regions due to climate change, population growth, and increased ...
The Centers for Disease Control and Prevention (CDC) yesterday declared its investigation into a multistate Salmonella ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results